Prognosis
N.J. Sees 20% Spike; Bidens Receive Pfizer Vaccine: Virus Update
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Pfizer Inc. and BioNTech SE’s Covid-19 vaccine won the backing of a key European review panel, clearing the way for inoculations to start before year-end.